Flemming Steen Jensen insider trades: Ascendis Pharma A/S (ASND) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Flemming reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ASND | ↓ Sell | 19,460 | $238.49 | $4.6M | Direct | May 12, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ASND insiders
Open-market trades in the last 12 months
About Flemming Steen Jensen's insider trades
Flemming Steen Jensen is See Remarks at Ascendis Pharma A/S (ASND). Since May 11, 2026, Flemming has reported no open-market purchases and 1 sale worth $4.6M on SEC Form 4. In the last 12 months: 1 sale ($4.6M).
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ASND insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.